Spruce Biosciences, Inc., a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, has appointed Brian Walls as Vice President, Market Access and Darren M. Johnson as Vice President, Commercial Operations. “We are thrilled to welcome Brian and Darren to our team. Brian and Darren are proven commercial leaders who bring highly complementary expertise that is critical to a successful rare dis...